Skip to content

Effect of subthalamic nucleus stimulation for pain related to Parkinson's disease

Effect of subthalamic nucleus stimulation for pain related to Parkinson's disease - STN stimulation for PD-related pain

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000005360
Enrollment
70
Registered
2011-04-01
Start date
2005-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson disease

Interventions

None listed

Sponsors

Nihon University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Advanced idiopathic PD is diagnosed in all patients and refer to us by neurologists with an intimate knowledge of the pharmacological treatment of PD. Our surgical indication criteria for STN stimulation is clinically diagnosed advanced idiopathic PD which demonstrate evidence of a good response to levodopa, and a Hoehn and Yahr staging that is within the range of stages III-V during the off-period and stage III or less in the best on-condition despite treatment with optimal pharmacological therapies. by our group

Exclusion criteria

Exclusion criteria: Patients with major depression or cognitive dysfunction (Mini-Mental Status Examination score < 23) are excluded as candidates for surgery.

Design outcomes

Primary

MeasureTime frame
Data are collected from this cohort prospectively. All patients describe the severity of their pain according to a visual analogue scale (VAS; 0-10.0 points) preoperatively and at 2 weeks, 6 and 12 months postoperatively.

Secondary

MeasureTime frame
Unified Parkinson's Disease Rating Scale (UPDRS) is scored during the on-period and off-period with sustaining anti-parkinsonian agents. The levodopa-induced dyskinesias (LID) are categorized into three groups; off-period, diphasic, and on-period dyskinesia. The dyskinesia severity rating scale is employed to evaluate the severity of each of LID, scoring the dyskinesia in 6 body parts (neck, trunk, and each of the 4 extremities) on a 5-point scale (ranging from 0 to 4; e.g. 0=absent, 4=severe). All patients are also assessed for their mood using the Hamilton depression scale and their cognitive function by using Mini-Mental Status Examinations.

Countries

Japan

Contacts

Public ContactHideki Oshima

Nihon University School of Medicine Neurological Surgery

hoshima@med.nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026